A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases
about
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapyClinical Translation of Nanomedicine.Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
P2860
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A phase I study of hepatic art ...... d predominant liver metastases
@ast
A phase I study of hepatic art ...... d predominant liver metastases
@en
type
label
A phase I study of hepatic art ...... d predominant liver metastases
@ast
A phase I study of hepatic art ...... d predominant liver metastases
@en
prefLabel
A phase I study of hepatic art ...... d predominant liver metastases
@ast
A phase I study of hepatic art ...... d predominant liver metastases
@en
P2093
P2860
P1476
A phase I study of hepatic art ...... d predominant liver metastases
@en
P2093
David Hong
Jennifer Wheler
Kenneth R Hess
Robert A Wolff
Uchechi Nwosu
P2860
P2888
P304
P356
10.1007/S00280-013-2088-Y
P577
2013-02-03T00:00:00Z
P6179
1009679898